 |
 |
 |
 |
 |
||||||||||||||
Moderate to Severe Hypertension A 12-week, Phase 3b on patients with severe to moderate hypertension Why This Trial Is Important If your blood pressure is greater than 160/90, you may be eligible for our clinical trial. TAK-491 is being developed as a possible treatment for high blood pressure. It works by relaxing the blood vessels and reducing workload on the heart. TAK-491 is an investigational drug and is still in development.
Who Can Join This Trial? Men or women over the aged of 18 years old with moderate to severe hypertension. Study Site and Contact Information Southeastern Research Group Please contact us if you are interested in participating in this study. |
|
|||||||||||||||
 |
 |
